Switzerland· 66475001
Rexulti 0.5 mg, Filmtabletten
A brexpiprazole product containing brexpiprazolum, registered in Switzerland by Lundbeck (Schweiz) AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Brexpiprazole is registered in 12 of 19 countries.
Countries holding a registration under ATC N05AX16 (brexpiprazole), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Brexpiprazole · ATC N05AX16
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of brexpiprazole costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- Switzerland: $8.31 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Brexpiprazole · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$8.31
The record
At a glance
Swissmedic (Switzerland)- Active substance
- brexpiprazolum
- Manufacturer
- Lundbeck (Schweiz) AG
- Country
- Switzerland (CH)
- ATC code
- N05AX16
- ATC class
- Brexpiprazole
- Defined daily dose
- 3 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680664750010Blist 7 StkCHF 16.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
209 interactions on record for brexpiprazole.
Graded by severity as the source publishes them — 52 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brexpiprazole · interactions on record
209 records
- 52 severe
- 157 moderate
Most severe, free to view
- ClotrimazoleA01AB18severe
- CimetidineA02BA01severe
- MetoclopramideA03FA01severe
- DiphenhydraminA04AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brexpiprazole in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRxulti 0.5 mgOtsuka Pharmaceutical Netherlands
- CzechiaRXULTIOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- SpainRXULTI 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULAOtsuka Pharmaceutical Netherlands B.V.
- FinlandRxultiOtsuka Pharmaceutical Netherlands B.V.
- IrelandRXULTI 0.5 mg Film-coated tabletOtsuka Pharmaceutical Netherlands B.V.
- IcelandRxultiOtsuka Pharmaceutical Netherlands B.V.*
- NetherlandsRXULTI 0,5 mg filmomhulde tablettenOtsuka Pharmaceutical Netherlands B.V.
- NorwayRxultiOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rxulti
- Liechtenstein · Rxulti
- Norway · Rxulti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee9b2ff5-d6d8-4997-90ea-a74439c452cb GET /v1/drugs/ee9b2ff5-d6d8-4997-90ea-a74439c452cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "brexpiprazolum 0.5 mg",
"valid_from": "2021-01-01",
"limitations": null,
"galenic_form": "Filmtabl 0.5 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2019-01-01",
"self_retention_pct": 10
}See everything about brexpiprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.